MENLO PARK, Calif.--(BUSINESS WIRE)--Meliora Therapeutics, a biotech company pioneering a machine learning-driven platform to decipher oncology drugs’ true mechanisms-of-action, announced today the ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...

Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...

Researchers published a new study, “Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution,” in Cell that they say solves the mystery of what drives the genomic ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

At certain point of cancer progression, primary localized tumors may disseminate to distant organs, including lymph nodes, lungs, bones, liver, or brain. The current options to treat cancer metastases ...

As the landscape of cancer treatment evolves, fusion genes stand at the forefront of precision medicine, offering new hope for patients. With continuous advancements in genomic research and targeted ...

Lung cancer remains the leading cause of cancer-related deaths globally, with cigarette smoking as its primary driver.